From the Department of Biochemistry and Molecular Biology, School of Biomedical Sciences, Monash University, Building 13D, Melbourne, Victoria 3800, Australia
Received for publication, September 22, 2002, and in revised form, October 21, 2002
![]() |
ABSTRACT |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
We employed a highly specific photoaffinity
labeling procedure, using 14C-labeled
S-adenosyl-L-methionine (AdoMet) to define the
chemical structure of the AdoMet binding centers on cyclosporin
synthetase (CySyn). Tryptic digestion of CySyn photolabeled with either
[methyl-14C]AdoMet or
[carboxyl-14C]AdoMet yielded the sequence
H2N-Asn-Asp-Gly-Leu-Glu-Ser-Tyr-Val-Gly-Ile-Glu-Pro-Ser-Arg-COOH (residues 10644-10657), situated within the
N-methyltransferase domain of module 8 of CySyn.
Radiosequencing detected Glu10654 and Pro10655
as the major sites of derivatization.
[carboxyl-14C]AdoMet in addition labeled
Tyr10650. Chymotryptic digestion generated the radiolabeled
peptide
H2N-Ile-Gly-Leu-Glu-Pro-Ser-Gln-Ser-Ala-Val-Gln-Phe-COOH, corresponding to amino acids 2125-2136 of the
N-methyltransferase domain of module 2. The
radiolabeled amino acids were identified as Glu2128 and
Pro2129, which are equivalent in position and function to
the modified residues identified with tryptic digestions in module 8. Homology modeling of the N-methyltransferase domains
indicates that these regions conserve the consensus topology of the
AdoMet binding fold and consensus cofactor interactions seen in
structurally characterized AdoMet-dependent
methyltransferases. The modified sequence regions correspond to the
motif II consensus sequence element, which is involved in directly
complexing the adenine and ribose components of AdoMet. We conclude
that the AdoMet binding to nonribosomal peptide synthetase
N-methyltransferase domains obeys the consensus cofactor
interactions seen among most structurally characterized low molecular
weight AdoMet-dependent methyltransferases.
Biologically active, low molecular weight peptides of microbial
origin have found a niche in medicine, agriculture, and biological research, by virtue of their enormous structural and functional diversity. A veritable plethora of these compounds exhibit structural modifications such as N-methylated peptide bonds. The
natural cyclosporins are products of cyclosporin synthetase
(CySyn),1 a very complex high
molecular mass (1.7-MDa) single polypeptide chain nonribosomal peptide
synthetase (NRPS) (1, 2). The major natural product of the enzyme,
cyclosporin A, is a cyclic undecapeptide that contains three
nonproteogenic amino acids (D-alanine, (4R)-4-[(E)-2-butyl]-4-methyl-L-threonine
(Bmt), and L-2-aminobutyric acid) and seven
N-methylated peptide bonds (3). To date, it remains the drug
of choice used in transplantation surgery and in the treatment of
autoimmune diseases (4, 5). In addition to its immunosuppressive
action, cyclosporin A exhibits several other biological activities,
including anti-fungal (6), anti-inflammatory (7, 8), anti-parasitic
(9), and anti-human immunodeficiency viral (10, 11) properties.
The nonribosomal biosynthetic assembly of cyclosporins proceeds via a
protein template-driven mechanism (12-14). CySyn catalyzes a total of
40 reactions in the synthesis of the cycloundecapeptide product (1, 2,
12). CySyn is composed of 11 conserved modules, which are each arranged
into functional domains that catalyze the activation, modification, and
polymerization of the constituent amino acids of the peptide product
(15-18). The order of these semiautonomous modules is co-linear with
the sequence of the peptide product (14, 18). The fundamental module
unit consists of catalytic domains responsible for substrate amino acid
activation (A-domain), thiolation (T-domain, synonymous with peptidyl
carrier protein), and condensation (C-domain) (19, 20). Together, these
domains form the functional NRPS repeating unit, which represents the
minimal domain set necessary for peptide elongation. Often these
modules carry an additional modification domain of ~430 amino acids
between the A- and T-domains. Functional and sequence analyses have
indicated that this region represents an N-methyltransferase
(N-MTase) function in CySyn (1, 12, 18, 21). In the process
of nonribosomal peptide assembly, activation of the substrate amino
acid occurs at the A-domain through the generation of a transient
aminoacyl adenylate that is in turn covalently attached via a thioester
linkage to the thiol of the 4'-phosphopantetheinyl prosthetic cofactor
of the T-domain in the respective module (18, 22, 23). The peptide is
elongated in a linear NH2- to COOH-terminal direction with successive rounds of trans-thiolations and
trans-peptidations between each activated amino acid
facilitated by the interplay of 4'-phosphopantetheinyl internal
carriers. This sequence of events is repeated in a stepwise fashion
until the consummation of peptide assembly. In the case of cyclosporin
synthesis, release of the full-length peptide ensues via cyclization.
Prokaryotic NRPSs usually employ a thioesterase domain
(TE-domain) situated at the extreme COOH terminus of the last module
(24, 25), whereas most fungal NRPSs, such as CySyn, utilize a unique
COOH-terminal C-domain for cyclization and release of the mature
peptide (26).
CySyn contains four basic C-A-T modules (modules 1, 6, 9, and 11); the
other seven modules (modules 2, 3, 4, 5, 7, 8, and 10) display the
additional N-MTase domain insert between the A- and
T-domains (Fig. 1) (18). Whereas analysis of the mechanism of action of
the domains forming the catalytic triad has progressed well during
recent years, characterization of the modification domains, and
especially the N-MTase domain, is still in its infancy. Methyltransferases (MTases) are enzymes that catalyze the transfer of
the methyl group from the ubiquitous cofactor
S-adenosyl-L-methionine (AdoMet) to nitrogen,
oxygen, sulfur, or carbon atoms of a range of small molecules and
macromolecular species (27). These enzymes can be divided into families
according to four major substrate classes, protein, RNA, DNA, and small
molecule (27). The N-MTase domains of NRPS catalyze the
bimolecular transfer of the S-methyl group of AdoMet to the
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-nitrogen of the thioesterified amino acid, releasing
S-adenosyl-L-homocysteine as a reaction product (Fig. 1) (1, 12). Accordingly, these
N-MTase domains can be assigned as small molecule
MTases.
View larger version (23K):
[in a new window]
Fig. 1.
Spatial organization of the functional
domains in CySyn modules responsible for the incorporation of
N-methylated amino acids. A module (1100-1500
aa) consists of all of the functional domains required to incorporate a
residue into the peptide chain. All CySyn modules contain
domains responsible for the activation (A; ~550 aa),
thiolation (T; ~100 aa), and condensation (C;
~450 aa) reactions of peptide assembly. In addition to this essential
catalytic domain triad, N-methylating modules exhibit an
N-MTase (M; ~420 aa) inserted between the A-
and T-domains responsible for the transfer of the methyl moiety of
AdoMet to the cognate amino acid of the module, whereas it is
covalently tethered to the respective modular 4'-phosphopantetheinyl
prosthetic group.
Most AdoMet-dependent MTases have a bilobial structure and
are organized into an AdoMet binding domain, which provides cofactor binding contacts and catalytic residues, and a second domain mainly responsible for conferring substrate specificity (27). Despite the poor
overall sequence identity across AdoMet-dependent MTases and varied substrate specificity, these enzymes display a structurally conserved cofactor-binding domain termed the "AdoMet-binding fold" (27-29). Moreover, a structural conservation of the mode of cofactor binding is observed across most structurally defined members of this
superfamily; this has led to the delineation of a set of consensus
AdoMet binding interactions (28). In most AdoMet-dependent MTases, the AdoMet binding region is constructed from a set of noncontiguous sequence elements. The low overall level of sequence identity across MTases has complicated the assignment of specific motifs to AdoMet binding. Kagan and Clarke (30) defined a set of three
conserved sequence motifs, which are apparent in most non-nucleic acid
MTases (Fig. 2). Subsequently, a
structure-guided sequence alignment of several structurally
characterized AdoMet-dependent MTases revealed, motifs I
and II participate directly in cofactor binding, whereas motif III
serves a structural role, forming the core of -strand 5 of the
AdoMet-binding fold (Fig. 2) (27). More importantly, this comparison
indicated that the key residues governing the interactions with the
cofactor molecule are localized within four motifs, I-IV (27). In this
paper, we shall adopt the AdoMet binding motif nomenclature as defined
by Faunam et al. (27). In most MTases, these motifs occur in
the same linear order and are separated by similar intervals in the
polypeptide (27, 30, 31).
|
Although much progress has been made toward the understanding of
the catalytic mechanism of various protein and DNA methyltransferases, the assignment of unambiguous, specific amino acid sequence motifs to
AdoMet binding and catalysis of N-methylation have not been established for NRPS. We have previously demonstrated that
[methyl-14C]AdoMet can be utilized to directly
photolabel the N-MTase domains of CySyn in a highly specific
manner.2 In this study,
stochiometric photoaffinity labeling demonstrated that CySyn is
photolabeled with AdoMet in a molar ratio of ~7:1 (AdoMet/CySyn),
which is in good agreement with the seven N-MTase domains
identified in the CySyn cDNA sequence. The specificity of
photolabeling was demonstrated by competitive displacement by unlabeled
AdoMet and its congeners S-adenosyl-L-ethionine, S-adenosyl-L-homocysteine, and sinefungin.
Photolabeling was only tenable with native CySyn and was not detected
with denatured enzyme or with proteins, which do not bind AdoMet. The
photolabeling of the AdoMet binding sites displayed homotropic negative
cooperativity, characterized by a curvilinear Scatchard plot with
upward concavity. Here we have employed a combination of classical
photoaffinity labeling and peptide mapping techniques to define the
specific amino acid sequences involved in the cofactor interaction. We also present a three-dimensional homology model of the cofactor binding
interaction with the N-MTase domains of CySyn. The proposed bimolecular interaction model provides a satisfactory
structure-function rationale for the photoaffinity labeling data and
conforms agreeably to homologous cofactor interactions defined from
structurally characterized AdoMet-dependent MTases. To our
knowledge, this is the first report of a structure-related
characterization of the N-MTase domains of a NRPS. Due to
the high degree of sequence identity conserved across NRPS, the
information garnered from this study can be generalized to all NRPS
family members expressing an N-MTase function.
![]() |
EXPERIMENTAL PROCEDURES |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Materials-- S-Adenosyl-L-[methyl-14C]methionine ([methyl-14C]AdoMet; 58 mCi/mmol) and S-adenosyl-L-[carboxyl-14C]methionine ([carboxyl-14C]AdoMet; 60 mCi/mmol) were purchased from PerkinElmer Life Sciences. Bmt and cyclosporin A were donated by Dr. R. Traber (Novartis Ltd., Basel, Switzerland). All other chemicals used were from Sigma or Merck and of the highest purity commercially available. Flat bottom microtiter plates were purchased from NUNC (Roskilide, Denmark).
Growth of Organism and Enzyme Preparation-- Tolypocladium inflatum Syn. Beauveria nivea, strain 7939/45 was donated by Dr. M. Dreyfuss (Novartis) and cultured as previously described (32). CySyn was purified to near homogeneity as described earlier (1) with minor modifications to the protocol. 25 g of lyophilized mycelium was ground to a fine powder and extracted with 500 ml of buffer A (200 ml of 1 M Tris-HCl, pH 7.8; 150 ml of 2 M KCl; 40 ml of 0.1 M EDTA, pH 7, 10 mM dithioerythritol, 40% (w/v) glycerol) and centrifuged for 10 min at 10,000 rpm and 4 °C. Nuclear material was precipitated from the supernatant with 0.3% polyethyleneimine and pelleted by centrifugation for 10 min at 10,000 rpm. The protein precipitated between 30 and 50% saturated (NH4)2SO4 was collected by centrifugation and resolubilized in buffer B (100 ml of 1 M Tris-HCl, pH 7.8, 40 ml 0.1 M EDTA, pH 7, 15% (w/v) glycerol, 4 mM dithioerythritol). The protein suspension was resolved by gel filtration on Fractogel EMD BioSEC, pore size 0.2-0.4 mm (Merck). Active fractions were pooled and concentrated. Aliquots (1 ml) of the concentrate were loaded onto a 50-25% (w/v) stabilized glycerol gradient in buffer C (0.1 mM Tris-HCl, pH 7.8, 50 mM KCl, 4 mM EDTA, 4 mM dithioerythritol). The samples were subjected to ultracentrifugation, first for 6 h at 10,000 rpm and subsequently for an additional 48 h at 22,000 rpm. Active fractions are pooled and once again subjected to glycerol gradient ultracentrifugation, yielding fractions of CySyn of electrophoretic purity (Coomassie Brilliant Blue G-250 staining).
Thin Layer Chromatography-- Two-dimensional high performance thin layer chromatography (HPTLC) of peptide digests was performed according to Pataki (33). For developing the chromatograms, butanol/acetic acid/water (4:1:1) (solvent A) was used in the first dimension, and phenol/water (75:25) (solvent B) was used in the second dimension (33). Amino acid standards were detected with ninhydrin reagent (0.3% in acetone); for development, the chromatogram was sprayed and heated at 60 °C for 20 min. The radiolabeled material was visualized by autoradiography, and the developed film was in turn superimposed onto the ninhydrin-stained HPTLC sheet to allow for correlation with the position of amino acid standards. Where specified, material was scraped from the plates and analyzed by electrospray ionization-mass spectrometry (ESIMS).
Photoaffinity Labeling of CySyn-- Samples of CySyn preparations were incubated together with 0.25 µCi of [14C]AdoMet in a 96-well microtiter plate precooled on ice and allowed to equilibrate for 1 h prior to photoirradiation. Photolabeling was induced by irradiation of the reaction mixture at 4 °C for 15 min with short wave ultraviolet (254 nm).
Isolation of [14C]AdoMet-photolabeled Peptides and
Localization of the Modified Residues--
For large scale preparative
photolabeling, 2-mg samples of CySyn were photolabeled with
[14C]AdoMet. The photolabeled protein was first partially
digested by incubation with sequencing grade modified trypsin or
chymotrypsin (Sigma) at a protease/substrate ratio of 1:125 (w/w) at
37 °C for 1.5 h. The reaction was terminated by the addition of
a protease inhibitor mixture (Sigma catalog no. P2714) and an equal
volume of SDS-PAGE sample buffer. The resultant fragments were resolved by SDS-PAGE on a 12% polyacrylamide gel. The gel was dried, and photolabeled fragments were visualized by phosphorimaging. The apparent molecular masses of the photolabeled fragments were determined by comparison with the mobility of molecular mass standards (Bio-Rad). Prominent photolabeled bands generated from the partial tryptic and
chymotryptic digests of ~56 and ~60 kDa, respectively, were excised from dried gels using the phosphor image as a template. They were rehydrated with 300 µl of elution buffer (0.1 M
NH4HCO3, 0.1% SDS) and finely crushed. The
labeled protein was passively eluted from the macerated gel pieces into
5 ml of elution buffer for 3 days with agitation. The eluent was
separated from the gel by centrifugation to prevent the protein from
reentering the gel. The elution was repeated three times to maximize
the recovery of protein from the gel. The eluents were filtered with a
0.45-µm syringe filter (Pall Gelman Sciences, Sydney, New South
Wales, Australia) and combined, and the protein was precipitated with 5 volumes of acetone at 20 °C overnight to concentrate and remove excess SDS. The protein precipitate was pelleted by centrifugation at
13,000 × g for 15 min, and the supernatant was
discarded. The pellet was resuspended in digestion buffer (0.1 M NH4HCO3, 2 M urea, pH
8.0). To ensure complete reaction, the radiolabeled protein fragment
was reduced by incubation with 45 mM dithiothreitol at 55 °C for 30 min, the mixture was then cooled to room temperature, and iodoacetamide was added to a final concentration of 100 mM. The mixture was then incubated for 30 min in the dark
to alkylate the cysteinyl thiol groups. The protein fragment was then
exhaustively digested with either trypsin or chymotrypsin 1:25 (w/w)
for 2 days at 37 °C. After 4 and 20 h of incubation, the
initial amount of protease was added again to the reaction. Preparative
purification of the photolabeled tryptic peptides was achieved by
several successive reverse phase-high performance liquid chromatography
(HPLC) runs. The digested sample was dried, resuspended in 0.05%
trifluoroacetic acid in water, and subjected to reverse phase
HPLC on a Zorbax 300-Å C18 column (3.5 µm; 4.6 mm × 250 mm; Agilent Technologies, Melbourne, Victoria, Australia) using
0.05% trifluoroacetic acid in water (solvent C) and 0.05%
trifluoroacetic acid in acetonitrile (solvent D). The peptides were
eluted by a linear gradient from 0 to 80% solvent D in 80 min at a
constant flow rate of 0.75 ml/min. The eluent was monitored at 214 nm,
fractions were collected, and aliquots of each fraction were assayed
for radioactivity by liquid scintillation counting. The radioactive
peak fractions were dried and reconstituted in 0.05% trifluoroacetic
acid in water and rechromatographed. The purified radioactive peptide fractions from successive runs were pooled, concentrated, and subjected
to NH2-terminal sequence analysis.
Purified [14C]AdoMet-modified peptides were also digested with pronase in 100 mM triethanolammonium acetate buffer, pH 6.8, for 12 h at 37 °C. The mixture was then boiled, eluted through a Sephadex G-25 M column, and concentrated. The concentrate was redissolved and digested for another 12 h at 25 °C with carboxypeptidase Y (400 µg/ml) in 100 mM triethanolammonium acetate buffer, pH 6.0. The digestion mixture was then boiled, eluted through a Sephadex G-25 M column, and concentrated. The concentrate was subjected to another round of proteolysis with proteinase K in 10 mM Tris-HCl buffer, pH 7.5, for 12 h at 37 °C. The digest was eluted through a Sephadex G-25 M column, dried and redissolved in 60 µl of water, and resolved by HPTLC.
Sequence Analysis-- Amino-terminal sequencing was performed on a ProciseTM (Applied Biosystems, Melbourne, Victoria, Australia) protein sequencer. Sequencing was performed at the Australian Proteome Analysis Facility. The dissolved peptide sample was applied onto a precycled Biobrene-treated trifluoroacetic acid glass fiber disk (Applied Biosystems) and subjected to cycles of Edman degradation following a modified pulse-liquid protocol. Phenylthiohydantoin (PTH)-derivative mass values were derived from a correlation of chromatographic peak heights of the PTH-derivatives released with each cycle with a standard 10-pmol mixture of the 20 proteogenic amino acids (Applied Biosystems). The theoretical initial yield and repetitive yield were calculated from linear least squares analysis of the semilogarithmic plot of the quantity (pmol) of PTH-derivative released with each cycle versus the cycle number. The low yielding residues Ser, Thr, and Trp were omitted from the analysis.
An aliquot of the PTH-derivatives released from each cycle was counted for 14C radioactivity; the remainder of the material was injected into the on-line HPLC PTH-derivative analysis system for identification.
ESIMS-- Mass values of purified photolabeled proteolytic peptides and modified amino acids were determined on a Micromass (Manchester, UK) Platform II liquid chromatography/mass spectrometry system.
Protein Assay-- Protein was determined by the dye-binding method of Bradford (34) using bovine serum albumin as a standard (prepared from fraction V, globulin-free; Sigma).
Sequence Alignment and Homology Analysis-- The sequence alignment of the seven N-methyltransferase domains of CySyn was performed using ClustalW (35). The protein sequence of CySyn (accession number Z28383) was retrieved from the EMBL nucleotide/protein sequence data base.
Model Generation and Molecular Docking--
A structural model
of the AdoMet binding site of the N-MTase domain of module 8 (N-MET M8) of CySyn was constructed using the experimental
structure of catechol-O-methyltransferase (RCSB Protein Data
Bank www.rcsb.org/pdb; PDB ID-1VID) as the modeling template. The model
was constructed using the Swiss-Model and Deep-Viewer environment
(36-38). The quality of the model was evaluated with the internal
WHATIF-Check program (39, 40). High resolution images of the model were
generated with the ray-tracer program POV-Ray version 3.01 (by
Christopher Cason; available on the World Wide Web at
www.povay.org).
![]() |
RESULTS |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Identification of the AdoMet Binding Region-- In order to define the amino acid sites at which AdoMet interacts with the N-MTase domains, samples of CySyn were photolabeled with either [methyl-14C]AdoMet or [carboxyl-14C]AdoMet on a preparative scale. The sites of photoinsertion were localized by sequential peptide mapping and Edman sequencing of isolated radioactive peptides. The high specificity of the photolabeling reaction has been demonstrated elsewhere.2
Initially, partial proteolytic digestion of the photolabeled enzyme
with either trypsin or chymotrypsin was performed. The resultant
fragments were resolved by SDS-PAGE and visualized by phosphorimaging.
Limited tryptic digestion generated a series of photolabeled fragments
migrating with apparent molecular masses ranging from 35 to 220 kDa
(Fig. 3a). The peptide
corresponding to the 56-kDa radiolabeled band was excised, eluted, and
digested to completion with trypsin. The resultant peptides were
resolved by reverse phase HPLC as described under "Experimental
Procedures." It was previously reported that the decomposition of
ligand-protein photoadducts during reverse phase HPLC is somewhat
dependent on the flow rate of separation (41). To circumvent this
shortcoming, a slow flow rate (0.75 ml/min) was employed in the reverse
phase HPLC separations of the proteolytic digests of photolabeled
protein fragments. Aliquots of each collected fraction were analyzed
for radioactivity (Fig. 3b). In the two independent
preparative scale experiments performed, radioactivity consistently
eluted in three peaks (labeled A-C). The major peak, C,
corresponded to fractions eluting between 43 and 45 min, whereas the
two minor peaks, B and A, eluted at 32-35 min and with the void
volume, respectively. Comparable elution profiles were obtained with
both [methyl-14C]AdoMet- and
[carboxyl-14C]AdoMet-photolabeled samples. The
radioactive fractions corresponding to radioactive peak C (indicated by
the arrow in Fig. 3a) were pooled and
rechromatographed until a single peptide peak was obtained (Fig.
3c). The material from each of the radioactive peaks was subjected to NH2-terminal sequence analysis. Radioactive
peaks A and B did not yield any sequence information and therefore most likely represent unbound radioligand and/or decomposition products of
the photoadduct, which may be unstable under reverse phase HPLC
conditions.
|
Edman sequencing of the purified material from radioactive peak C
isolated from either [methyl-14C]AdoMet- or
[carboxyl-14C]AdoMet-photolabeled samples
yielded a single 14-residue sequence, H2N-Asn-Asp-Gly-Leu-Glu-Ser-Tyr-Val-Gly-Ile-Glu-Pro-Ser-Arg-COOH. By comparison with the established cDNA sequence of CySyn, the sequence could be unambiguously assigned to residues 10644-10657, situated in N-MET M8 (Fig. 2). The specific residues
modified in the peptide were identified from the release of
radioactivity during each cycle of the Edman degradation (Fig.
4, a and b). In
both [methyl-14C]AdoMet- and
[carboxyl-14C]AdoMet-photolabeled
preparations, a significant radioactivity release was observed with
cycles 11-14. The majority of radioactivity release coincides with
cycles 11 and 12, consistent with photoincorporation at
Pro10655 and, to a lesser extent, Glu10654. A
substantial decrease in the yield of the PTH-derivative of the
corresponding residues is also observed (Fig. 4, a and
b). Furthermore, the output chromatogram from the on-line
HPLC PTH-derivative analyzer obtained from cycles 11 and 12 from both
samples shows an extraneous peak lagging close to the representative
PTH-derivative peak of the Glu and Pro residues (data not shown).
Moreover, radioactive peak C, corresponding to the labeled peptide,
displays a lagging shoulder; this may represent a distinct photoadduct,
which would account for the minor level of photoincorporation detected
in the Glu10654. In the case of the
[carboxyl-14C]AdoMet-photolabeled sample, a
significant release of radioactivity also occurred in cycle 7, corresponding to Tyr10650. An attenuated yield of the
PTH-derivative of this residue was also observed; in addition, the
output HPLC chromatogram of the PTH-derivatives from this cycle
displayed an extraneous peak that does not correspond to any of the
PTH-derivative standards (data not shown). The radioactivity coinciding
with this cycle is significantly less than the radioactivity release
observed with cycles 11 (Glu10654) and 12 (Pro10655), suggesting that these sites are preferentially
labeled as opposed to the Tyr10650 position. The lower
degree of photoincorporation observed at the Tyr and Glu positions may
be due to the adduct at these sites being more labile to the conditions
of Edman sequencing or possibly due to a lower inherent propensity of
photoinsertion at these sites. These findings indicate that the
photoinsertion of [14C]AdoMet is heterogeneous, with
modification occurring on at least three disparate sites.
|
It is also noteworthy that these residues may not represent the exclusive sites of photoincorporation, since a considerable proportion of radioactivity was lost during both reverse phase HPLC and sequencing processes. However, in comparison with the proteolytic peptides derived from [methyl-14C]AdoMet-modified preparations, far less background radioactivity was released with each cycle from [carboxyl-14C]AdoMet-modified peptide preparations. The low levels of radioactivity release observed with cycles 13 and 14 can be attributed to carryover from unreacted NH2-terminal residue from cycles 11 and 12, which is one of the primary complications associated with the Edman procedure. Taking into consideration the observed loss of radioactivity during reverse phase HPLC and the background release of radioactivity during Edman degradation, it appears that the photolabeled amino acid derivatives are slowly hydrolyzed at the pH conditions of HPLC and Edman sequencing.
The purified peptides were further analyzed by ESIMS in positive ionization mode. The observed mass of each species corresponds to the calculated monoisotopic mass of each nonlabeled peptide species plus the mass of one AdoMet molecule (Table I). Although the nature of the modification remains obscure, these data confirm that the entire AdoMet molecule is photocross-linked to the enzyme.
|
To confirm the above results, the proteolytic mapping experiment was
repeated with chymotrypsin. The different specificity of this protease
led to the isolation of a peptide derived from N-MET
M2 of CySyn. Mild chymotryptic cleavage of the
[14C]AdoMet-photolabeled enzyme generated fragments
ranging in molecular mass from 26 to 200 kDa (Fig.
5a). A ~60-kDa fragment was
isolated and further digested with chymotrypsin. The resultant peptides were separated by reverse phase HPLC. Aliquots of the peak fractions were assayed for radioactivity. Consistent with the results of the
tryptic digestion, the elution profile displayed three radioactive peaks (Fig. 5b). The fractions corresponding to the
prominent peak (peak C) were pooled from successive runs, concentrated, and purified to homogeneity by rechromatography (Fig. 5c).
NH2-terminal sequence analysis of peaks A and B did not
yield any sequence, whereas the pooled fractions from peak C yielded a
single peptide, H2N-Ile-Gly-Leu-Glu-Pro-Ser-Gln-Ser-Ala-Val-Gln-Phe-COOH.
This peptide corresponds to residues 2125-2136 of CySyn, situated in N-MET M2 (Fig. 2). Both the
[methyl-14C]AdoMet- and
[carboxyl-14C]AdoMet-labeled peptides yielded
the same sequence.
|
The radioactivity profile of each peptide indicates that the radioactivity release occurs primarily during cycle 5, corresponding to Pro2129, and to a lesser extent in cycle 4, corresponding to Glu2128 (Fig. 4, c and d). A concomitant decrease in the yields of the PTH-derivatives of these residues is also observed (Fig. 4, c and d). Moreover, the HPLC profiles for these residues displayed an extraneous peak not corresponding to any of the standard amino acids (data not shown). These data indicate Pro2129 as the primary and Glu2128 as the secondary site of [14C]AdoMet photoincorporation on the peptide, suggesting that these residues form an intimate interaction with the cofactor. The results confirmed the photolabeling data obtained from tryptic peptides and showed that photolabeling occurs at the same residue positions in different N-MTase domains of CySyn.
ESIMS analysis of the purified peptides indicated that the mass of each species corresponds to the calculated monoisotopic mass of each nonlabeled peptide species plus the mass of one AdoMet molecule (Table I).
Two-dimensional HPTLC Analysis-- To confirm the sites of photoinsertion, the photolabeled peptides were digested to composite amino acids with a combination of proteases and analyzed by two-dimensional HPTLC and ESIMS. The digest of the [methyl-14C]AdoMet-photolabeled tryptic peptide yielded two major radioactive spots, whereas the digest of the [carboxyl-14C]AdoMet-photolabeled tryptic peptide yielded three radioactive species. The migration of these compounds did not correlate with any of the 20 proteogenic amino acid standards (data not shown). The radioactive compounds were extracted from the plates, rechromatographed, and analyzed by ESIMS. The observed masses of the radioactive material from the three spots derived from tryptic digestion of the [carboxyl-14C]AdoMet photolabeled peptide correspond well to the calculated monoisotopic masses for one [14C]AdoMet molecule plus the mass of the amino acids Tyr, Asp, and Pro, respectively (Table II). The observed molecular masses of the two spots derived from tryptic digestion of the [methyl-14C]AdoMet-photolabeled CySyn correspond well to the calculated theoretical values of the masses of one AdoMet molecule plus the masses of the amino acids Asp and Pro, respectively (Table II). The amino acids Asp and Pro were also obtained from the chymotryptic peptides. These data are in conformity with the radiosequencing results and further substantiate the identity of the modified residues
|
Model Generation--
The conserved tertiary topology of the
AdoMet binding fold and equivalence of the order and spacing of the
AdoMet binding motifs allow for the prediction of the structure of the
AdoMet binding site of the N-MTase domains of CySyn. The
N-MTase domains of CySyn were modeled based on the consensus
folding topology of rat catechol-O-methyltransferase (27,
42). The homologous architecture of the AdoMet binding region in
catechol-O-methyltransferase exhibits a doubly wound open
/
Rossmann-type fold topology (27, 42, 43). The three-dimensional
model of the N-MET M8 region of CySyn is presented (Fig.
6a); comparable results were
obtained with modeling of the other six N-MTase domains of
CySyn. The model was generated from the sequence region spanning
residues 10,603-10,780 based on a structure-guided alignment of
consensus motifs I-IV in the template and target sequence. The root
mean square deviation of superimposed C
atoms was 0.5 Å, indicating that the structures are almost indistinguishable; thus,
the model fits the experimentally derived template structure very well.
The modeled structure accommodates the same secondary structural
elements and tertiary positioning of AdoMet binding contact points from
consensus regions I-IV. The consensus structural topology consists of
a seven-stranded
-sheet of mixed strand polarity sandwiched by six
-helices (Fig. 6b). The central
-sheet consists of
five parallel
-strands with a topological organization
(5
4
1
2
3
) and two anti-parallel
-strands (6
7
).
Three of the helices (A-C) are at the front of the sheet, and three
(D-F) are at the back of the sheet, creating an
/
/
secondary
structural succession. Moreover, the structure shows internal symmetry;
the
-
-
-
segment encompassing
-strands 1 and 2 and
-helices B and C can be superimposed onto that encompassing
-strands 4 and 5 and
-helices E and F. This secondary structural arrangement creates a topological switch point between
-strands 1 and 4 where the strand order reverses, producing a cleft that forms the
cofactor binding pocket (27). The walls of the binding pocket are
formed by the
to
adjoining loops diverging from the COOH
termini of
-strands 1-4. Since the structure of
catechol-O-methyltransferase was employed as the modeling
template, the cofactor molecule was docked into the macromolecular
surface in the extended conformation. However, the cofactor is bound in
a distorted conformation in some MTases; hence, the extended
conformational interaction should not be taken as absolute (44).
|
The consensus AdoMet binding motifs are present in the
N-MTase domains of CySyn; motif I is clearly discernible,
whereas the unambiguous assignment of residue blocks to motifs II-IV
is not plausible without structural guidance due to the sequence
heterogeneity in these regions (Fig. 2). The spatial location of the
AdoMet binding motifs in the N-MTase domains of CySyn is
also consistent with the spacing of these elements in other small
molecule MTases (Fig. 2) (27, 30). On the primary level, motif I is
characterized by a glycine-rich stretch; the consensus sequence is
represented by GXGXG in non-nucleic acid
AdoMet-dependent MTases (30). This motif is highly
conserved and is the signature sequence for
AdoMet-dependent MTases. In the proposed model, this motif
forms the adjoining loop (termed the G-loop (31)) between -strand 1 and
-helix B, which accommodates the methionine moiety of AdoMet.
This region represents a common structural element of the AdoMet
binding cleft of these enzymes (28). The conserved glycines allow for
hydrogen bonding of the main chain atoms to the carboxyl and amino
groups of the AdoMet methionine (Fig.
7). Within the cleft of the G-loop, the
amino group of the AdoMet methionine is hydrogen-bonded by the main
chain oxygen of Gly10631, whereas the main chain nitrogen
of Gly10635 hydrogen-bonds with the methionine
carboxyl.
|
Motif II is more heterogeneous on the primary level but invariably
contains an acidic residue followed by a hydrophobic or aliphatic
residue, which is commonly involved in stabilizing the binding of the
adenine ring of AdoMet by van der Waals packing in a face-to-face or
edge-to-face fashion. In most structurally defined
AdoMet-dependent MTases, the highly conserved acidic
residue plays a direct role in AdoMet binding by hydrogen-bonding with the hydroxyls of the adenine ribose (27, 28, 31). In the homology
model, motif II forms the loop (termed the D-loop (31)) at
the COOH terminus of -strand 2; the conserved acidic residue, represented by the photolabeled Glu10654, is centered at
the end of
-strand 2 and forms hydrogen bonds to the ribose
hydroxyls of AdoMet (Figs. 6 and 7). In the predicted structure of
N-MET M8, the binding of the adenine ring is stabilized by
van der Waals packing in a perpendicular fashion with
Pro10655 adjacent to the conserved Glu10654 of
the D-loop (Fig. 7). Considering that the photolabeled
Pro10655 is in close proximity to the adenine ring, it is
possible that the observed modification at this site may have resulted
from destabilization of the
-bond state of the adenine ring.
Motif III contributes hydrogen-bonding contacts to the N-1 and
N-6 atoms of the adenine ring of AdoMet. In the proposed model, motif III is centered at the COOH terminus of -strand 3, the exocyclic amino group (N-6) of the AdoMet adenine ring hydrogen-bonds to the side chain of the conserved Asp10686, with its main
chain nitrogen hydrogen-bonding to the N-1 atom of adenine (Fig.
7).
Motif IV is located in the loop region at the COOH terminus of
-strand 4. In nucleic acid MTases, this region is well conserved (45-47), whereas in non-nucleic acid AdoMet-dependent
MTases the region is poorly conserved and no consensus has been
defined. In NRPS N-MTase domains, this region is represented
by the conserved sequence block NSV(A/V)QYFP (Fig. 2) (48). The model
implies that the conserved Gln10705 forms hydrogen bonds
with the amino and carboxylate of the AdoMet methionine, whereas the
adjacent Tyr10706 and Phe10707 make
edge-to-face van der Waals contacts with opposite sides of the adenine
ring (Fig. 7).
![]() |
DISCUSSION |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Very little is known about the chemical mechanisms of cofactor
binding and the steric course of N-methyl transfer in NRPS systems, and to date no structural data have been garnered. We have
employed a highly specific photoaffinity labeling procedure in
combination with proteolytic mapping and Edman degradation to define
the primary structural elements involved in AdoMet binding in the
N-MTase domain regions of CySyn. Our data suggest that the
cofactor binds to topologically equivalent sites on the seven N-MTase domains of CySyn. Radiosequencing of the isolated
photolabeled peptides indicates a heterogeneous photolabeling with
mutually exclusive modification at three amino acid positions. This was confirmed by proteolytic digestion of the peptides and ESIMS analysis of the composite residues. The [14C]AdoMet peptides
obtained from both tryptic and chymotryptic fragmentations correspond
to the consensus motif (Gly-Leu-Xaa-Xaa-Tyr-Val-Gly-Leu-Asp/Glu-Pro), which is conserved across the N-MTase domains of several
NRPS systems from both eukaryotic and prokaryotic organisms (48). This
region is homologous to the small molecule AdoMet-dependent MTases motif II consensus sequence element
(P/G)(Q/T)(F/Y/A)DA(I/V/Y)(F/I)(C/V/L) (30). In an early photoaffinity
labeling study of the N-MTase domain of enniatin synthetase
(49), which fell short of identifying the labeled amino acid(s), AdoMet
photolabeling was proteolytically mapped to a nonapeptide fragment
(2098H2N-Asn-Leu-Asn-Pro-Gly-Leu-Asn-Ser-Tyr-COOH2106).
This peptide is homologous to the photolabeled proteolytic peptides
identified in this study. Considering the data together, it is evident
that the cofactor interacts with homologous sequence elements within
the cofactor-binding site of the N-MTase domains of distinct
NRPS systems. Furthermore, both studies are in line with a study of rat
guanidinoacetate MTase, which identified a Tyr residue within the
AdoMet-binding motif II region of this enzyme as forming the covalent
adduct with AdoMet (50, 51). The recent resolution of the crystal
structure of rat guanidinoacetate MTase revealed that this residue is
proximal to the AdoMet binding pocket of this enzyme (52). The primary
structure of these peptides also contains homologous residues,
identified as the photocross-linking sites in this study. The
COOH-terminal Tyr2106 of the peptide from enniatin
synthetase corresponds to the modified Tyr10650 observed in
the [carboxyl-14C]AdoMet-photolabeled tryptic
peptide fragment from CySyn.Moreover, mutation of
Tyr2106 to Ala in the recombinant enniatin synthetase
N-MTase domain resulted in a pronounced reduction in AdoMet
photolabeling (48), suggesting that the side chain of this residue is
involved in integral contacts with the cofactor and/or maintenance of
the binding site. The presence of several contact points, in addition to Tyr10650, identified in this study would account for the
inability of this substitution to completely abolish AdoMet binding.
Although our experimental results concur with these data, the homology model of the N-MET M8 of CySyn implies that the modified
Tyr10650 serves a structural role and is situated within
-strand 2 of the AdoMet binding fold. The observed
photoincorporation at the Tyr10650 position can be
construed in terms of the vectorial structural movements initiated with
AdoMet photolabeling.2 It is likely that these
conformational transitions move the Tyr10650 sufficiently
close to the ligand to undergo photocross-linking. Such vectorial
interdomain movements are commonplace in multifunctional polypeptides
(53, 54).
Although it is not represented in the homology model, it is tenable
that the aromatic ring of the conserved Tyr10650 position
acts to stabilize cofactor binding via a cation- interaction with
the electron-deficient sulfonium center of the AdoMet molecule (Fig.
8a). If the
Tyr10650 side chain does indeed stabilize AdoMet binding by
an electrostatic interaction with the sulfonium center, then the
polarization of the positively charged sulfonium sulfur would
facilitate the methyl transfer reaction (55). Evidence for a similar
mechanism has been proposed for the reaction mechanisms of the DNA
MTases M.TaqI (56) and M.HhaI (57). This
aromatic-cation interaction would also serve to stabilize the possible
cationic N-methyl-amino acid reaction intermediate prior to
subsequent proton abstraction (Fig. 8b) (56). This postulate
is substantiated by evidence that the stabilization of the cationic
transition state through cation-
interactions accelerates catalysis
of biomimetic methylation reactions (58, 59). Moreover, this is
consistent with the proposed interaction of the AdoMet molecule with
the conserved motif IV region, which is rich in aromatic residues (Fig.
2). The involvement of cation-aromatic interactions in ligand binding
to proteins has been reported in a number of systems (60-63). Aromatic
residues in proteins are believed to act as attractive cation binding
sites by providing stabilizing interactions with the positive charge of
ligands conferred through their electron-rich
systems.
|
It is conceivable that the steric hindrance imposed by the modification at the corresponding Tyr position (Tyr2124) in N-MET M2 would inhibit chymotryptic cleavage of the peptide backbone at this site. However the positional heterogeneity of photoinsertion and the very low yield of the Tyr-labeled fragment would account for the isolation of the [14C]AdoMet-labeled H2N-Ile-Gly-Leu-Glu-Pro-Ser-Gln-Ser-Ala-Val-Gln-Phe-COOH peptide as the major photolabeled chymotryptic fragment derived from N-MET M2. Therefore, the labeled peptide mixture isolated via reverse phase HPLC predominantly consists of the Glu and Pro derivatized species.
ESIMS analysis of the purified peptides demonstrates that the entire AdoMet molecule is covalently attached to the photoreactive residues as opposed to the composite adenosine or methionine or the transmethylation of the S-methyl group from AdoMet to a specific site on the protein. This result accounts also for the fact that we were able to label CySyn with [carboxyl-14C]AdoMet in contrast to our earlier results (1). This difference is likely to be due to a slightly changed methodology employed in two different laboratories. These data also indicate that the observed labeling at the different residue positions on each peptide fragment is mutually exclusive with a stoichiometry of one AdoMet molecule per peptide.
Although our findings demonstrate an exclusive stoichiometry of photolabeling, the region of the AdoMet molecule, which is involved in the formation of the covalent cross-link and the precise photochemistry of the reaction, remains enigmatic. Early studies on the photochemical cross-linking of purines have shown that substitution/addition reactions can occur either across the 1,6 double bond (64) or C-8 position (65, 66) of the adenine moiety. It is tenable to imagine that a comparable photochemical reaction occurs in the case of the photoaffinity cross-linking of [14C]AdoMet to the N-MTase domains of CySyn.
The AdoMet binding domain of MTases exhibits a comparable three-dimensional folding (27-29). This structural similarity extends to the tertiary positions of the amino acid side chains interacting with the AdoMet molecule. These residue positions are located in motif elements that are highly conserved within a given MTases subfamily but only exhibit marginal sequence identity to the corresponding regions of other MTases subfamilies. Based on this common AdoMet binding domain architecture and equivalent motif positioning, we have constructed three-dimensional models of the AdoMet binding region of the N-MTase domains of CySyn. The architecture of the putative AdoMet binding domain predicts that the N-MTases domains of CySyn conserve the consensus AdoMet binding contacts defined from comparisons of several structurally characterized AdoMet-dependent MTases (28). The molecular determinants of the AdoMet binding site in the N-MTase domain regions can all be mapped to four noncontiguous sequence elements, which display positional and distant sequence identity to the cofactor binding motif regions of non-nucleic acid MTases. Interpretation of the photoaffinity labeling data within the context of the presented N-MET M8 homology model of the cofactor interaction satisfactorily illustrates the role of the modified residues in the binding of the cofactor molecule.
The model indicates that the [14C]AdoMet-modified
peptides build a loop region between the -strand 2 and
-helix C
secondary structural elements. The heterogeneity of the photoadduct can be construed in terms of the inherent flexibility of polypeptides in
loop segments. The photolabeled amino acids are conserved within the
N-MTase domains of CySyn, and identical or equivalent
residue positions are observed within the N-MTase domain
regions of heterogeneous NRPS systems, which further supports the
importance of these residues for the recognition and binding of the
chemical structure of the AdoMet molecule. The model predicts the
modified Pro makes edge-to-face contacts with the AdoMet adenine,
whereas the side chain of the modified Glu hydrogen bonds to the ribose hydroxyls.
Many MTases are bilobial and, in addition to the core AdoMet binding region, display structurally unique accessory domains that function in substrate recognition. In comparison with the NH2-terminal AdoMet binding region, the COOH-terminal regions of the N-MTase domains of CySyn are more variable. Given that three of the seven N-MTase domains of CySyn N-methylate different amino acid substrates, it is likely that these COOH-terminal regions form the substrate recognition component. All AdoMet-dependent MTases possess AdoMet binding, substrate recognition, and methyl transfer functions. The NH2- to COOH-terminal order of these regions varies between MTase classes (31). Based on this common architecture, we suggest that NRPS N-MTase domains are functionally organized into AdoMet-binding catalytic substrate recognition regions from the NH2 to COOH terminus (Fig. 8c).
The significant level of sequence conservation seen among a given subfamily of MTases allows for the allocation of specific motifs that are inherent to that subfamily to either cofactor binding or substrate recognition. In addition to the four cofactor binding motifs, the N-MTase domains of CySyn display several unique conserved sequence blocks that are innate only to the N-MTase domains of NRPS (Fig. 2). The functional significance of these conserved residues remains unknown, but site-directed mutagenesis of these specific sites should in the future allow us to further refine the contemporary model.
The present consensus is that the evolution of MTases with differing substrate specificities resulted from the formation of hybrid enzymes (28, 31). It is believed that the COOH-terminal regions have been exchanged, allowing for the recognition of new substrate targets without modification of the AdoMet binding scaffold. The N-MTase domains of NRPS may have originated from monomeric MTases that fused with the peptide synthetase genes. Given the diverse forms of modifying domains that have been identified in NRPS systems (67), it seems that the alteration of the secondary metabolite biosynthetic genes to confer changes in the structure and bioactivity of the product is a common phenomenon.
The present work presents the first structural information on the
identity and location of the AdoMet binding site within the
N-MTase domains of CySyn. The homology model presented
provides a satisfactory structure-function rationale for the
photoaffinity labeling data and a valuable insight into the bimolecular
interaction. The model also presents the basis for the analysis and
design of site-directed N-MTase mutants to elaborate
structure-function studies. The results of this study indicate that the
binding of AdoMet to the N-MTase domains of CySyn obeys the
consensus AdoMet binding pattern observed in most structurally
characterized MTases. It appears the binding of AdoMet is governed by
interactions within four noncontiguous sequence elements, which are
conserved across members of this MTase subfamily. Given the high degree
of sequence homology shared among NRPS N-MTase domains, the
findings presented herein serve as a paradigm of AdoMet binding in
these systems.
![]() |
ACKNOWLEDGEMENT |
---|
We thank Dr. René Traber for valuable comments on the manuscript.
![]() |
FOOTNOTES |
---|
* The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
To whom correspondence should be addressed. Tel.: 61-3-9905-3711;
Fax: 61-3-9905-3726; E-mail: Alfons.Lawen@med.monash.edu.au.
Published, JBC Papers in Press, October 23, 2002, DOI 10.1074/jbc.M209719200
2 Velkov, T., and Lawen, A. (2003) Photochem. Photobiol., in press.
![]() |
ABBREVIATIONS |
---|
The abbreviations used are: CySyn, cyclosporin synthetase; AdoMet, S-adenosyl-L-methionine; A-domain, adenylation domain; Bmt, (4R)-4-[(E)-2-butenyl]-4-methyl-L-threonine; C-domain, condensation domain; ESIMS, electrospray ionization mass spectrometry; HPLC, high performance liquid chromatography; HPTLC, high performance thin layer chromatography; MTase, methyltransferase; N-MTase, N-methyltransferase; N-MET M2 and N-MET M8, N-methyltransferase domain of module 2 and 8, respectively, of CySyn; NRPS, nonribosomal peptide synthetase; PTH, phenylthiohydantoin; T- domain, thiolation domain; aa, amino acids.
![]() |
REFERENCES |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
1. |
Lawen, A.,
and Zocher, R.
(1990)
J. Biol. Chem.
265,
11355-11360 |
2. | Lawen, A. (1996) Prog. Med. Chem. 33, 53-97[Medline] [Order article via Infotrieve] |
3. | Rüegger, A., Kuhn, M., Lichti, H., Loosli, H-R., Huguenin, R., Quiquerez, C., and von Wartburg, A. (1976) Helv. Chim. Acta 59, 1075-1092[Medline] [Order article via Infotrieve] |
4. | Borel, J. F., and Hiestand, P. C. (1999) Transplant. Proc. 31, 1464-1471[CrossRef][Medline] [Order article via Infotrieve] |
5. | Ciancio, G., Burke, G. W., and Miller, J. (2000) Exp. Opin. Pharmacother. 1, 1307-1330[Medline] [Order article via Infotrieve] |
6. |
Cruz, M. C.,
Del Poeta, M.,
Wang, P.,
Wenger, R.,
Zenke, G.,
Quesniaux, V. F. J,
Movva, N. R.,
Perfect, J. R.,
Cardenas, M. E.,
and Heitman, J.
(2000)
Antimicrob. Agents Chemother.
44,
143-149 |
7. |
Xu, Q.,
Leiva, M. C.,
Fischkoff, S. A.,
Handschumacher, R. E.,
and Lyttle, C. R.
(1992)
J. Biol. Chem.
267,
11968-11971 |
8. | Sherry, B., Yarlett, N., Strupp, A., and Cerami, A. (1992) Proc. Natl. Acad. Sci. U. S. A. 89, 3511-3515[Abstract] |
9. | Bell, A., Wernli, B., and Franklin, R. M. (1994) Biochem. Pharmacol. 48, 495-503[Medline] [Order article via Infotrieve] |
10. | Franke, E. K., and Luban, J. (1996) Virology 222, 279-282[CrossRef][Medline] [Order article via Infotrieve] |
11. | Luban, J., Bossolt, K. L., Franke, E. K., Kalpana, G. V., and Goff, S. P. (1993) Cell 73, 1067-1078[Medline] [Order article via Infotrieve] |
12. |
Dittmann, J.,
Wenger, R. M.,
Kleinkauf, H.,
and Lawen, A.
(1994)
J. Biol. Chem.
269,
2841-2846 |
13. | Lipmann, F., Gevers, W., Kleinkauf, H., and Roskoski, R., Jr. (1971) Adv. Enzymol. Relat. Areas Mol. Biol. 35, 1-34[Medline] [Order article via Infotrieve] |
14. | Marahiel, M. A. (1997) Chem. Biol. 4, 561-567[CrossRef][Medline] [Order article via Infotrieve] |
15. |
Stachelhaus, T.,
and Marahiel, M. A.
(1995)
J. Biol. Chem.
270,
6163-6169 |
16. | Stachelhaus, T., Schneider, A., and Marahiel, M. A. (1995) Science 269, 69-72[Medline] [Order article via Infotrieve] |
17. | Konz, D., and Marahiel, M. A. (1999) Chem. Biol. 6, R39-R48[CrossRef][Medline] [Order article via Infotrieve] |
18. | Weber, G., Schörgendorfer, K., Schneider-Scherzer, E., and Leitner, E. (1994) Curr. Genet. 26, 120-125[Medline] [Order article via Infotrieve] |
19. |
Stachelhaus, T.,
Mootz, H. D.,
Bergendahl, V.,
and Marahiel, M. A.
(1998)
J. Biol. Chem.
273,
22773-22781 |
20. | Weber, T., Baumgartner, R., Renner, C., Marahiel, M. A., and Holak, T. A. (2000) Structure 8, 407-418[Medline] [Order article via Infotrieve] |
21. | Haese, A., Schubert, M., Herrmann, M., and Zocher, R. (1993) Mol. Microbiol. 7, 905-914[Medline] [Order article via Infotrieve] |
22. | Stachelhaus, T., Hüser, A., and Marahiel, M. A. (1996) Chem. Biol. 3, 913-921[Medline] [Order article via Infotrieve] |
23. | Weinreb, P. H., Quadri, L. E. N., Walsh, C. T., and Zuber, P. (1998) Biochemistry 37, 1575-1584[CrossRef][Medline] [Order article via Infotrieve] |
24. | Trauger, J. W., Kohli, R. M., Mootz, H. D., Marahiel, M. A., and Walsh, C. T. (2000) Nature 407, 215-218[CrossRef][Medline] [Order article via Infotrieve] |
25. |
de Ferra, F.,
Rodriguez, F.,
Tortora, O.,
Tosi, C.,
and Grandi, G.
(1997)
J. Biol. Chem.
272,
25304-25309 |
26. | Keating, T. A., Ehmann, D. E., Kohli, R. M., Marshall, C. G., Trauger, J. W., and Walsh, C. T. (2001) Chembiochem 2, 99-107[CrossRef][Medline] [Order article via Infotrieve] |
27. | Faunam, E. B., Blumenthal, R. M., and Cheng, X. (1999) in S-Adenosylmethionine-Dependent Methyltransferases: Structures and Functions (Cheng, X. , and Blumenthal, R. M., eds) , pp. 1-38, World Scientific Publishing, Singapore |
28. | Schluckebier, G., O'Gara, M., Saenger, W., and Cheng, X. (1995) J. Mol. Biol. 247, 16-20[CrossRef][Medline] [Order article via Infotrieve] |
29. | Djordjevic, S., and Stock, A. M. (1997) Structure 5, 545-558[Medline] [Order article via Infotrieve] |
30. | Kagan, R. M., and Clarke, S. (1994) Arch. Biochem. Biophys. 310, 417-427[CrossRef][Medline] [Order article via Infotrieve] |
31. | Malone, T., Blumenthal, R. M., and Cheng, X. (1995) J. Mol. Biol. 253, 618-632[CrossRef][Medline] [Order article via Infotrieve] |
32. | Lawen, A., Traber, R., Geyl, D., Zocher, R., and Kleinkauf, H. (1989) J. Antibiot. 42, 1283-1289[Medline] [Order article via Infotrieve] |
33. | Pataki, G. (1967) Chromatogr. Rev. 9, 23-36[CrossRef][Medline] [Order article via Infotrieve] |
34. | Bradford, M. M. (1976) Anal. Biochem. 72, 248-254[CrossRef][Medline] [Order article via Infotrieve] |
35. | Thompson, J. D., Higgins, D. G., and Gibson, T. J. (1994) Nucleic Acids Res. 22, 4673-4680[Abstract] |
36. | Peitsch, M. C., Wells, T. N. C., Stampf, D. R., and Sussman, J. L. (1995) Trends Biochem. Sci. 20, 82-84[CrossRef][Medline] [Order article via Infotrieve] |
37. | Peitsch, M. C. (1996) Biochem. Soc. Trans. 24, 274-279[Medline] [Order article via Infotrieve] |
38. | Guex, N., and Peitsch, M. C. (1997) Electrophoresis 18, 2714-2723[Medline] [Order article via Infotrieve] |
39. | Vriend, G. (1990) J. Mol. Graph. 8, 52-56[CrossRef][Medline] [Order article via Infotrieve] |
40. | Hooft, R. W. W., Vriend, G., Sander, C., and Abola, E. E. (1996) Nature 381, 272[Medline] [Order article via Infotrieve] |
41. |
Chavan, A. J.,
Ensor, C. M., Wu, P.,
Haley, B. E.,
and Tai, H-H.
(1993)
J. Biol. Chem.
268,
16437-16442 |
42. | Vidgren, J., Svensson, L. A., and Liljas, A. (1994) Nature 368, 354-358[CrossRef][Medline] [Order article via Infotrieve] |
43. | Rossmann, M. G., Moras, D., and Olsen, K. W. (1974) Nature 250, 194-199[Medline] [Order article via Infotrieve] |
44. | Schubert, H. L., Wilson, K. S., Raux, E., Woodcock, S. C., and Warren, M. J. (1998) Nat. Struct. Biol. 5, 585-592[CrossRef][Medline] [Order article via Infotrieve] |
45. | Cheng, X., Kumar, S., Posfai, J., Pflugrath, J. W., and Roberts, R. J. (1993) Cell 74, 299-307[Medline] [Order article via Infotrieve] |
46. |
Ingrosso, D.,
Fowler, A. V.,
Bleibaum, J.,
and Clarke, S.
(1989)
J. Biol. Chem.
264,
20131-20139 |
47. | Pósfai, J., Bhagwat, A. S., Pósfai, G., and Roberts, R. J. (1989) Nucleic Acids Res. 17, 2421-2435[Abstract] |
48. |
Hacker, C.,
Glinski, M.,
Hornbogen, T.,
Doller, A.,
and Zocher, R.
(2000)
J. Biol. Chem.
275,
30826-30832 |
49. | Pieper, R., Haese, A., Schröder, W., and Zocher, R. (1995) Eur. J. Biochem. 230, 119-126[Abstract] |
50. | Takata, Y., and Fujioka, M. (1992) Biochemistry 31, 4369-4374[Medline] [Order article via Infotrieve] |
51. | Hamahata, A., Takata, Y., Gomi, T., and Fujioka, M. (1996) Biochem. J. 317, 141-145[Medline] [Order article via Infotrieve] |
52. | Komoto, J., Huang, Y., Takata, Y., Yamada, T., Konishi, K., Ogawa, H., Gomi, T., Fujioka, M., and Takusagawa, F. (2002) J. Mol. Biol. 320, 223-235[CrossRef][Medline] [Order article via Infotrieve] |
53. | Tsuji, S. Y., Wu, N., and Khosla, C. (2001) Biochemistry 40, 2317-2325[CrossRef][Medline] [Order article via Infotrieve] |
54. | Gokhale, R. S., and Khosla, C. (2000) Curr. Opin. Chem. Biol. 4, 22-27[CrossRef][Medline] [Order article via Infotrieve] |
55. | Dougherty, D. A. (1996) Science 271, 163-168[Abstract] |
56. | Schluckebier, G., Labahn, J., Granzin, J., and Saenger, W. (1998) Biol. Chem. 379, 389-400[Medline] [Order article via Infotrieve] |
57. | O'Gara, M., Zhang, X., Roberts, R. J., and Cheng, X. (1999) J. Mol. Biol. 287, 201-209[CrossRef][Medline] [Order article via Infotrieve] |
58. | McCurdy, A., Jimenez, L., Stauffer, D. A., and Dougherty, D. A. (1992) J. Am. Chem. Soc. 114, 10314-10321 |
59. | Ngola, S. M., and Dougherty, D. A. (1996) J. Org. Chem. 61, 4355-4360[CrossRef][Medline] [Order article via Infotrieve] |
60. | Dougherty, D. A., and Stauffer, D. A. (1990) Science 250, 1558-1560[Medline] [Order article via Infotrieve] |
61. | Sussman, J. L., Harel, M., Frolow, F., Oefner, C., Goldman, A., Toker, L., and Silman, I. (1991) Science 253, 872-879[Medline] [Order article via Infotrieve] |
62. | Ortiz, A. R., Pisabarro, M. T., Gallego, J., and Gago, F. (1992) Biochemistry 31, 2887-2896[Medline] [Order article via Infotrieve] |
63. | Scrutton, N. S., and Raine, A. R. C. (1996) Biochem. J. 319, 1-8[Medline] [Order article via Infotrieve] |
64. | Linschitz, H., and Connolly, J. S. (1968) J. Am. Chem. Soc. 90, 2979 |
65. | Elad, D., Rosenthal, I., and Steinmaus, H. (1969) Chem. Commun. 305-306 |
66. | Steinmaus, H., Rosenthal, I., and Elad, D. (1969) J. Am. Chem. Soc. 91, 4921-4923 |
67. | Walsh, C. T., Chen, H., Keating, T. A., Hubbard, B. K., Losey, H. C., Luo, L., Marshall, C. G., Miller, D. A., and Patel, H. M. (2001) Curr. Opin. Chem. Biol. 5, 525-534[CrossRef][Medline] [Order article via Infotrieve] |
|
HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
All ASBMB Journals | Molecular and Cellular Proteomics |
Journal of Lipid Research | Biochemistry and Molecular Biology Education |